ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of CLR 131 in Relapsed or Refractory Select B-Cell Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02952508
Recruitment Status : Recruiting
First Posted : November 2, 2016
Last Update Posted : March 19, 2018
Sponsor:
Information provided by (Responsible Party):
Cellectar Biosciences, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : March 2019